Articles Tagged With:
-
Continuous Use of Non-androgenic OC Improves Endometriosis Pain and Endometrioma Reoccurrence
Compared to cyclic use, a drospirenone-containing oral contraceptive pill used in a continuous fashion after the removal of an endometrioma is associated with a reduction in dysmenorrhea, non-menstrual pelvic pain, and reoccurrence of endometrioma formation. -
Annual Mammography Screening: The Debate Continues
Although annual screening mammography did increase the detection rate of non-palpable tumors, it did not reduce mortality from breast cancer over 25 years of follow-up. -
Adding to Survival ( Again): Cervix Cancer
Bevacizumab added to chemotherapy, particularly paclitaxel and cisplatin, was efficacious in all response outcomes (objective response, progression-free survival, and overall survival) without diminution in quality of life or unacceptable toxicity. -
Spironolactone for Heart Failure
-
The CORAL Trial: Is This the End for Renal Artery Stenting?
-
TAVR in the Real World: The Initial 18 months' Experience in the United States
-
Safety of Eplerenone in Heart Failure Patients
-
Infectious Disease Malpractice: The $1.2 Million Miscommunication
-
Two-step Screening for Ovarian Cancer: A ‘Scissor-step’ Forward?
-
IRB creates user-friendly chart review application